2025 annual financial data
Zentalis Pharmaceuticals 2025 Net income growth
Direct answer
Net income growth was 17.35%.
Operating income was -152,808,000 USD and net income was -137,060,000 USD.
Operating cash flow was -125,247,000 USD.
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -152,808,000 USD
- Net income
- -137,060,000 USD
- Operating cash flow
- -125,247,000 USD